Empowered Funds
ANIK icon

Empowered Funds’s Anika Therapeutics ANIK Stock Holding History

Empowered Funds’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$338K Buy
+17,208
New +$330K ﹤0.01% 1985

Other funds holding ANIK

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
CM
Capital Management Glen Allen, Virginia $668M AUM 8.93% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Empowered Funds's ANIK Position: Q3 2026 in Review

Empowered Funds opened a new position in Anika Therapeutics (ANIK) in Q3 2026: 17,208 shares worth $338K. The stake represents ﹤0.01% of the portfolio and ranks #1985 among its holdings.

97 funds tracked by Wall St. Rank hold ANIK as of Q3 2026.

  • Empowered Funds held 17,208 shares of Anika Therapeutics worth $338K as of Q3 2026.
  • Anika Therapeutics was a new Empowered Funds position in Q3 2026.
  • Anika Therapeutics made up ﹤0.01% of Empowered Funds's portfolio in Q3 2026, its #1985 holding.
  • 97 funds tracked by Wall St. Rank held Anika Therapeutics as of Q3 2026.

Based on Empowered Funds's 13F filing for Q3 2026, filed 13 Nov 2026.